X-ray fluorescence imaging reveals subcellular biometal disturbances in a childhood neurodegenerative disorder
A Grubman, SA James, J James, C Duncan, I Volitakis, JL Hickey, PJ Crouch, PS Donnelly, KM Kanninen, JR Liddell, SL Cotman, MD de Jonge, AR White
Chemical Science | ROYAL SOC CHEMISTRY | Published : 2014
Related Projects (7)
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Awarded by National Institutes of Health: National Institute of Neurological Disorders Stroke
Awarded by ARC Future Fellowship
Parts of this work were performed at the XFM beamline at the Australian Synchrotron, Victoria, Australia. This work was supported by the National Health and Medical Research Council of Australia (NHMRC)  and the National Institutes of Health: National Institute of Neurological Disorders & Stroke [R01NS073813]. ARW is a recipient of an ARC Future Fellowship [FT100100674]. The funding sources had no influence in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication. Patent protection has previously been sought by the University of Melbourne for the use of bis(-thiosemicarbazones) for treatment of diseases. ARW and PSD are co-inventors on this patent application PCT/AU2007/001792, which is the subject of a commercialization contract between the University and a private company. The company has not funded nor contributed to research described in this manuscript.